A database that tracks dubious medical claims.
Response number: 83
Date of response: Feb. 2, 2012
Type of response: Ruling
Final Appeals Committee of ASA overturned earlier ruling that Solal advert violated appendix F.
Claims dealt with in this response
- Claim no 58: Solal Technologies Increases risk of heart attack, diabetes, depression and arthritis Omega deficiency made on 2010-10-04 - Untested and implausible
See full ruling at: http://www.asasa.org.za/ResultDetail.aspx?Ruling=5946